Five Questions

  • What to know about concussions

    Angela Lumba-Brown, MD, co-director of the Stanford Concussion and Brain Performance Center, is the lead author of the newly published CDC Guidelines on the Management of Mild Traumatic Brain Injury in Children. In a recent interview, she explained what families should know about concussions.

  • Innovations in kids’ MRI scans

    Stanford pediatric radiologist Shreyas Vasanawala is tailoring MRI equipment to children. His work allows young patients to receive faster MRI exams that require less anesthesia.

  • Zulman on engaging high-need patients

    Patient engagement requires creativity, trust building and flexibility from health care providers, especially when treating high-need patients, a new Stanford study says.

  • New therapy for drug-resistant epilepsy

    The FDA has approved the use of an implanted device that releases periodic electrical discharges in the brain to counteract seizures in people with epilepsy. In an interview, neurologist Robert Fisher described the technology and Stanford’s role in testing the device.

  • Ioannidis on nutrition research

    Stanford's John Ioannidis recently discussed why the design of most nutrition studies impedes progress in the field and suggested a new kind of approach.

  • How border separations can traumatize kids

    Unplanned separation from parents is among the most damaging events a young child can experience, according to trauma research. A Stanford expert explains how it can hurt kids’ development.

  • IUD device aids contraception in India

    Stanford researchers and their colleagues have tested a new contraceptive device that they say could provide broader access to long-acting contraception in developing countries.

  • Could Nipah virus become global pandemic?

    Stephen Luby discusses risk factors and potential interventions for Nipah virus, a disease with no vaccine and a mortality rate of up to 70 percent.

  • Progress toward precision health

    A perspective piece from Stanford scientists provides an overview of the value of precision health, its progress, challenges and how it can improve health at the individual and population level.

  • Ioannidis on antidepressant efficacy

    In a highly comprehensive meta-analysis of more than 500 clinical trials, researchers from around the world have drawn conclusions about the efficacy of 21 different antidepressants.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.